Jump to content
  • Sign Up
0
Scott Adams

Microtest to make ImmusanT celiac vaccine for trials - Mass High Tech

Rate this topic

Recommended Posts

Microtest to make ImmusanT celiac vaccine for trials

Mass High Tech

By Rodney H. Brown ImmusanT Inc. has picked Agawam's Microtest Laboratories to manufacture the Cambridge biotech's Nexvax2 immunotherapeutic vaccine for its expected upcoming clinical trial as a treatment for celiac disease. ...

Microtest Laboratories Will Manufacture ImmusanT's Nexvax2 Immunotherapeutic ... MarketWatch (press release)

all 9 news articles »

View the full article

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
0

×